Dashboard
Manage Tickers

GLYC


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

glycomimetics-anticipates-recognizing-about-36m-in-total-charges-in-connection-with-headcount-reduction-a-restructuring-that-includes-a-reduction-in-companys-workforce-by-26-employees-or-80-of-its-headcount
GlycoMimetics Anticipates Recognizing Abou...
07/30/2024 19:58:37

- SEC Filing

td-cowen-downgrades-glycomimetics-to-hold
TD Cowen Downgrades GlycoMimetics to Hold
07/26/2024 18:45:01

TD Cowen analyst Boris Peaker downgrades GlycoMimetics (NASDAQ:GLYC) from Buy to Hold.

glycomimetics-to-conduct-additional-clinical-trial-for-uproleselan-in-rr-acute-myeloid-leukemia-after-fda-meeting-initiates-strategic-review-and-corporate-restructuring-reducing-workforce-by-80-engages-lucid-capital-markets-as-strategic-advisor-advancing-phase-23-study-of-uproleselan-in-newly-diagnosed-aml-patients-with-nci-and-alliance-for-clinical-trials-cash-expected-to-fund-company-into-q2-2025
GlycoMimetics To Conduct Additional Clinic...
07/25/2024 13:01:44

on-june-21-glycomimetics-got-notice-from-nasdaq-co-is-not-in-compliance-with-nasdaqs-listing-rule-5450a1
On June 21, GlycoMimetics Got Notice From ...
06/26/2024 20:35:46

- SEC Filing

why-glycomimetics-stock-is-trading-higher-monday
Why GlycoMimetics Stock is Trading Higher ...
06/25/2024 16:06:19

On Tuesday, the chief medical officer Edwin Rock disclosed in a Form4 that he bought 305 thousand shares in the company.

glycomimetics-form-4-filing-shows-cmo-edwin-rock-bought-305000-shares-at-an-average-price-of-026share
GlycoMimetics Form 4 Filing Shows CMO Edwi...
06/24/2024 20:35:28

- SEC Filing 

1m-bet-on-this-penny-stock-check-out-these-4-stocks-under-2-insiders-are-aggressively-buying
$1M Bet On This Penny Stock? Check Out The...
06/21/2024 12:22:05

hc-wainwright--co-reiterates-neutral-on-glycomimetics
HC Wainwright & Co. Reiterates Neutral on ...
06/04/2024 20:12:22

HC Wainwright & Co. analyst Edward White reiterates GlycoMimetics (NASDAQ:GLYC) with a Neutral.

glycomimetics-shares-detailed-results-from-its-pivotal-phase-3-study-of-uproleselan-in-relapsedrefractory-acute-myeloid-leukemia
GlycoMimetics Shares Detailed Results From...
06/04/2024 11:09:16

Company exploring path forward for uproleselan in multiple AML settings based on observed efficacy results, including clinica...

glycomimetics-to-host-leader-event-to-review-results-from-pivotal-phase-3-study-of-uproleselan-in-relapsedrefractory-acute-myeloid-leukemia-on-june-4-2024
GlycoMimetics To Host Leader Event To Revi...
05/29/2024 20:03:25

GlycoMimetics, Inc. (NASDAQ:GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based the...

dow-surges-over-100-points-eyepoint-pharmaceuticals-shares-plunge
Dow Surges Over 100 Points; EyePoint Pharm...
05/06/2024 19:04:00

hc-wainwright--co-downgrades-glycomimetics-to-neutral
HC Wainwright & Co. Downgrades GlycoMimeti...
05/06/2024 18:00:43

HC Wainwright & Co. analyst Edward White downgrades GlycoMimetics (NASDAQ:GLYC) from Buy to Neutral.

crude-oil-gains-1-treehouse-foods-shares-fall-after-q1-results
Crude Oil Gains 1%; TreeHouse Foods Shares...
05/06/2024 16:48:16

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/06/2024 16:31:16

nasdaq-jumps-100-points-tyson-foods-sales-miss-views
Nasdaq Jumps 100 Points; Tyson Foods Sales...
05/06/2024 15:14:07

glycomimetics-uproleselan-flunks-in-late-stage-leukemia-study-shares-sink
GlycoMimetics' Uproleselan Flunks In Late ...
05/06/2024 13:13:23

Get insights on GlycoMimetics Inc's Phase 3 study results for uproleselan in R/R AML patients. Explore survival rates, adve...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/06/2024 12:06:38

as-of-march-31-2024-glycomimetics-had-cash-and-cash-equivalents-of-313m-compared-to-418m-as-of-december-31-2023
As Of March 31, 2024, Glycomimetics Had Ca...
05/06/2024 11:27:07

glycomimetics-announces-results-of-pivotal-phase-3-study-of-uproleselan-in-relapsedrefractory-rr-acute-myeloid-leukemia-aml
GlycoMimetics Announces Results of Pivotal...
05/06/2024 10:09:52

GlycoMimetics, Inc. (NASDAQ:GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based th...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 20:31:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION